Does your risk for COVID increase because of your IBD? Does your medical therapy increase your risk? Should you change your medication schedule? See advice from the Crohn’s and Colitis Foundation here.
Inflammatory bowel disease patients who take antidepressants may also get relief from their inflammation, according to a study published in Inflammatory Bowel Diseases. “Apart from improving mood, it is observed that the anti-inflammatory properties of antidepressants may influence the inflammatory response directly,” the authors wrote. “Other research suggests a bidirectional relationship between IBD activity and
Patients with inflammatory bowel disease and GI cancers were more likely to get vaccinations such as flu shots after a consultation with a health care provider, according to a study published in Alimentary Pharmacology & Therapeutics. IBD and GI cancer patients have a high risk of contracting flu or pneumococcus, but the vaccination rate is
Assessing which care guideline to follow can be a challenge for many providers who care for patients with inflammatory bowel diseases (IBD). To help IBD health care professionals navigate these complexities, the 2019 Crohn’s & Colitis Congress® will focus its opening session on How to Make Sense of Care Guidelines. See Dr. David Rubin from the University
An estimated 30-50%, and possible 60%, of patients with inflammatory bowel disease (IBD) turn to complementary and alternative medicines (CAM’s) to ease symptoms and exert more control over their treatment. Very few studies have evaluated CAM’s, and many of the studies were small, poorly designed, and uncontrolled. Predictors of CAM use include dissatisfaction with conventional therapies,
Research published in the journal Alimentary Pharmacology & Therapeutics found ulcerative colitis patients with higher BMIs had a greater likelihood of biologic treatment failure. Increases in BMI also were associated with a higher risk of surgery or hospitalization. The reasons might be related to endogenous steroid production, misuse of medical steroids, or underdosing of conventional
Neurologic involvement in inflammatory bowel disease (IBD) is uncommon but probably underreported, and gastroenterologists must be ready to recognize it. For example, peripheral neuropathy is reported to occur in up to 13% of IBD patients. Neurologic complications due to nutritional deficiencies are thought to be even more common. Complications may arise spontaneously from the systemic inflammation
Delay in IBD diagnosis may be linked to stunted growth in children
Canadian researchers found an independent correlation between delay in pediatric inflammatory bowel disease diagnosis and height impairment, with every one standard deviation decrease in height-to-age z-score tied to a nearly 70% higher diagnostic delay risk. The findings in the Archives of Disease in Childhood also showed an independent link between bloody diarrhea and a reduced
Clinical measures can predict risks in acute severe colitis A study in the Journal of Gastroenterology and Hepatology found evaluating clinical features in patients with acute severe colitis may help predict the long-term risk of colectomy and steroid dependence. The four measures included in the study were patient response on day seven of hospitalization, steroid
The contribution of environmental factors, diet, and related issues like the status of the microbiome once again come into focus in a recent medical article. A Canadian study in The American Journal of Gastroenterology linked living in a rural area with a lower risk of inflammatory bowel disease. The protective effect was particularly strong among
